These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 18295343

  • 1. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ, Nakonezny PA, Rush AJ.
    Psychiatry Res; 2008 May 30; 159(1-2):115-20. PubMed ID: 18295343
    [Abstract] [Full Text] [Related]

  • 2. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine.
    Nakonezny PA, Byerly MJ, Rush AJ.
    J Sex Marital Ther; 2007 May 30; 33(3):203-16. PubMed ID: 17454518
    [Abstract] [Full Text] [Related]

  • 3. An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction.
    Byerly MJ, Lescouflair E, Weber MT, Bugno RM, Fisher R, Carmody T, Varghese F, Rush AJ.
    J Sex Marital Ther; 2004 May 30; 30(5):325-32. PubMed ID: 15672600
    [Abstract] [Full Text] [Related]

  • 4. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
    Byerly MJ, Nakonezny PA, Bettcher BM, Carmody T, Fisher R, Rush AJ.
    Schizophr Res; 2006 Sep 30; 86(1-3):244-50. PubMed ID: 16730951
    [Abstract] [Full Text] [Related]

  • 5. A new atypical antipsychotic: quetiapine-induced sexual dysfunctions.
    Atmaca M, Kuloglu M, Tezcan E.
    Int J Impot Res; 2005 Sep 30; 17(2):201-3. PubMed ID: 15284834
    [Abstract] [Full Text] [Related]

  • 6. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning.
    Knegtering R, Castelein S, Bous H, Van Der Linde J, Bruggeman R, Kluiter H, van den Bosch RJ.
    J Clin Psychopharmacol; 2004 Feb 30; 24(1):56-61. PubMed ID: 14709948
    [Abstract] [Full Text] [Related]

  • 7. Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
    Lam MH, Fong SY, Wing YK.
    Psychiatry Clin Neurosci; 2007 Jun 30; 61(3):333. PubMed ID: 17472606
    [No Abstract] [Full Text] [Related]

  • 8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 30; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 9. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
    Perez V, Cañas F, Tafalla M, TESIS Study Group.
    Int Clin Psychopharmacol; 2008 May 30; 23(3):138-49. PubMed ID: 18408528
    [Abstract] [Full Text] [Related]

  • 10. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
    Gharabawi G, Bossie C, Turkoz I, Kujawa M, Mahmoud R, Simpson G.
    J Nerv Ment Dis; 2007 Dec 30; 195(12):976-82. PubMed ID: 18091190
    [Abstract] [Full Text] [Related]

  • 11. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M.
    Psychiatr Danub; 2011 Dec 30; 23(4):384-8. PubMed ID: 22075740
    [Abstract] [Full Text] [Related]

  • 12. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA, Morrens M, Sabbe BG.
    Clin Ther; 2008 Sep 30; 30(9):1565-89. PubMed ID: 18840365
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
    Honer WG, MacEwan GW, Gendron A, Stip E, Labelle A, Williams R, Eriksson H, STACK Study Group.
    J Clin Psychiatry; 2012 Jan 30; 73(1):13-20. PubMed ID: 21733490
    [Abstract] [Full Text] [Related]

  • 14. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, Stringfellow J, Ingenito G, Marder SR.
    Arch Gen Psychiatry; 2003 Jul 30; 60(7):681-90. PubMed ID: 12860772
    [Abstract] [Full Text] [Related]

  • 15. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.
    J Clin Psychiatry; 2004 Dec 01; 65(12):1624-33. PubMed ID: 15641867
    [Abstract] [Full Text] [Related]

  • 17. An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ, Nakonezny PA, Fisher R, Magouirk B, Rush AJ.
    Schizophr Res; 2006 Jan 31; 81(2-3):311-6. PubMed ID: 16298106
    [Abstract] [Full Text] [Related]

  • 18. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA, Vermani M, Jacobs L, Marcus M, Kong B, Lessard S, Galarraga W, Struzik L, Gendron A.
    J Anxiety Disord; 2008 Dec 31; 22(8):1480-6. PubMed ID: 18455360
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
    Mullen J, Jibson MD, Sweitzer D.
    Clin Ther; 2001 Nov 31; 23(11):1839-54. PubMed ID: 11768836
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM, Correll CU, Goff DC, Kirkpatrick B, Marder SR, Vester-Blokland E, Sun W, Carson WH, Pikalov A, Assunção-Talbott S.
    J Clin Psychiatry; 2009 Oct 31; 70(10):1348-57. PubMed ID: 19906340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.